| Authors: |
de Graaf M; Department of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Gielen RCAM; Department of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Balduzzi S; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Siesling S; Department of Research and Development, The Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands; Department of Health, Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., Linn SC; Departments of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Kok M; Department of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: m.kok@nki.nl. |
